This article is more than 5 years old. Information may no longer be current.

Systems biology approach needed for dry AMD research

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Finding treatments for dry age-related macular degeneration requires a large-scale, collaborative, systems biology approach.

Dry AMD, which currently has no treatment options, is a leading cause of blindness in people aged 65 years and older.

A report published in Nature Communications proposed researchers use a broad approach, integrating data available from clinical registries and biology to develop models and possibly treatments for dry AMD, a press release from the National Eye Institute said.

“This approach would integrate basic, genomic, preclinical, medical, pharmacological and clinical data into mathematical models of pathological processes at different stages of dry AMD in order to ask how relevant individual components act together within the living system,” Joan W. Miller, MD, chair of Harvard Medical School’s Department of Ophthalmology, said in the NEI release.

Reference:

Handa JT, et al. Nat Commun. 2019;doi:10.1038/s41467-019-11262-1.